CHC – The Cancer & Hematology Centers


Name of this trial: LIVIGNO-4 What type of cancer is this for? Non-Small Cell Lung Cancer, Non-Squamous Cell Cytology Who is this trial for? Patients with Lung Cancer that has metastasized to other areas of body who have never received treatment for their disease. What biomarkers are involved? NO EGFR, or NO ALK mutations allowed.